Matthew T. Gettman, M.D.

Closed for Enrollment

• A Study Evaluating Intraoperative Application Of Platelet-Rich Plasma To The Neurovascular Bundles During Nerve-Sparing Radical Prostatectomy: Initial Technical Description And Prospective Early Postoperative Outcomes Analysis Rochester, Minn.

  The purpose of this study is to determine the effectiveness and safety of applying platelet rich plasma to nerve bundles of patients who are undergoing radical prostate removal surgery to help the nerve bundles heal.

• A Survey of Perceptions and Acceptance of Wearable Technology for Health Monitoring in a Urological Patient Population. Rochester, Minn.

  The purpose of this study is to understand patient interest in use of wearable technology for monitoring health, assess patient willingness to use wearable device for healthcare monitoring, and to determine which wearable device that patients would prefer most.

• Assessment of DNA Methylation Markers in Benign Prostate Tissue Rochester, Minn.

  The purpose of this study is to identify DNA methylation (genetic) markers in non-cancerous prostate tissue, and compare with the markers previously found to be in prostate cancer tissue. This will provide data that can be used to identify genetic marker profiles to diagnose and provide prognosis for prostate cancer.

• Cardiovascular Health Understanding In Urologic Cancer Survivorship Patients Rochester, Minn.

  The purpose of this study is to quantify urologic oncology patient’s understanding of their cardiovascular health (CVH) and to evaluate how a patient’s understanding of their CVH is associated with oncologic outcomes.

• Feasibility Of Mobile Physical Activity Monitoring Devices In Urology Rochester, Minn.

  The purpose of this study is to evaluate the feasibility of perioperative electronic physical activity monitor use in a surgical population.

• Matched Comparison of Robotic and Open Prostatectomy - Long Term Outcomes Rochester, Minn.

  The objective of this study is to compare perioperative and oncologic outcomes of patients undergoing open and robotic prostatectomy for prostate cancer.

   

• Quality Of Life After Treatment For Bladder Cancer: The Bladder Cancer Survivorship Study Jacksonville, Fla., Rochester, Minn., Scottsdale/Phoenix, Ariz.

  The purpose of this study is to compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively and to identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer.

• Validation of Uroflow Trace (R) Mobile Application Rochester, Minn.

  The purpose of this study is to see if the Uroflow Trace (r) mobile application provides an accurate representation of urinary flow tracing by comparing it to a clinical device used daily in the clinic.